Eiger Cleared To Liquidate, Repay Creditors Under Ch. 11 Plan
By Alex Wittenberg · September 5, 2024, 6:43 PM EDT
Drug developer Eiger Biopharmaceuticals will wind down its business and distribute proceeds from sales of its rare-disease treatments to creditors and shareholders under a Chapter 11 plan approved by a Texas...
To view the full article, register now.